PARSIPPANY, N.J. (AP) – Watson Pharmaceuticals Inc. said that it is preparing to sell a generic version of the “morning after” pill.
Watson said the Food and Drug Administration approved its generic version of Plan B One-Step, an emergency contraceptive made by Teva Pharmaceutical Industries Ltd.
The company said it will start shipping its generic version immediately, and will market the drug under the name Next Choice One Dose.
The pill contains progestin, and it is an emergency contraceptive used to prevent pregnancy following intercourse. Watson said U.S. sales of Plan B One-Step totaled $88 million over the 12 months ended May 31.
Date: July 13, 2012
Source: Associated Press
Filed Under: Drug Discovery